A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain.
about
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron diseaseDrug therapy for pain in amyotrophic lateral sclerosis or motor neuron diseaseGlutamatergic substrates of drug addiction and alcoholismHigh-affinity glutamate transporters in chronic pain: an emerging therapeutic targetThe Sur1-Trpm4 Channel in Spinal Cord InjuryActivation of glutamate transporters in the locus coeruleus paradoxically activates descending inhibition in rats.Blockade of persistent sodium currents contributes to the riluzole-induced inhibition of spontaneous activity and oscillations in injured DRG neurons.Effect of fluoxetine on disease progression in a mouse model of ALS.A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?HCN Channel Targets for Novel Antidepressant Treatment.Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injuryRiluzole is a promising pharmacological inhibitor of bilirubin-induced excitotoxicity in the ventral cochlear nucleus.Riluzole and gabapentinoids activate glutamate transporters to facilitate glutamate-induced glutamate release from cultured astrocytes.Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury.Antiallodynic effect of herbal medicine yokukansan on peripheral neuropathy in rats with chronic constriction injury.MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain.Bursting activity in myelinated sensory neurons plays a key role in pain behavior induced by localized inflammation of the rat sensory ganglionSmall-conductance calcium-activated potassium (SK) channels in the amygdala mediate pain-inhibiting effects of clinically available riluzole in a rat model of arthritis painSystemic pregabalin attenuates sensorimotor responses and medullary glutamate release in inflammatory tooth pain model.Effects of gabapentin on muscle spasticity and both induced as well as spontaneous autonomic dysreflexia after complete spinal cord injuryGabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic ratsPregabalin suppresses nociceptive behavior and central sensitization in a rat trigeminal neuropathic pain modelDelayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injuryCurrent approaches with the glutamatergic system as targets in the treatment of neuropathic pain.Review about gabapentin misuse, interactions, contraindications and side effects.Glutamatergic medications for the treatment of drug and behavioral addictions.Riluzole: what it does to spinal and brainstem neurons and how it does it.Implications and mechanism of action of gabapentin in neuropathic pain.VGLUTs in Peripheral Neurons and the Spinal Cord: Time for a Review.Glutamate transporter activators as anti-nociceptive agentsAutonomic dysreflexia after spinal cord injury: Systemic pathophysiology and methods of management.Gabapentin evoked changes in functional activity in nociceptive regions in the brain of the anaesthetized rat: an fMRI study.Glutamate Transport System as a Novel Therapeutic Target in Chronic Pain: Molecular Mechanisms and Pharmacology.Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia: a possibility for riluzole as a prophylactic drug.Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats.Glutamate release predicts ongoing myocardial ischemia of rat hearts.Comparison and effects of acute lamotrigine treatment on extracellular excitatory amino acids in the hippocampus of PTZ-kindled epileptic and PTZ-induced status epilepticus rats.Impairment of VGLUT2 but not VGLUT1 signaling reduces neuropathy-induced hypersensitivity.Amygdala Plasticity and Pain.Effects of gabapentin on brain hyperactivity related to pain and sleep disturbance under a neuropathic pain-like state using fMRI and brain wave analysis.
P2860
Q24202239-6B42D429-D913-430C-9E09-66F71B2ED070Q24242629-03980BC3-0ADF-4C37-8EBF-2F4B62FF221DQ24648924-BF606A39-0FA4-4C59-88C1-4A571A953B24Q27020953-B1E02652-F792-4E4C-A8CB-D8E8322F0501Q33602457-C5FFE22E-5131-455A-A656-FE73E2F79FBBQ33653421-0EA8DDD3-6986-4F09-A044-3CAEA174AFA8Q33889459-1D111884-DEE1-4CBC-92BF-1F573AAF4BC6Q33900692-5D7E1EE2-60D7-4C45-A3C5-4D3FB331A4A7Q34104378-381D8C02-8948-4463-8EFD-E4C6FFCBC617Q34557298-2D2EF967-9A1C-41BB-9E75-12B95258169FQ35006462-DAE4CD3E-B6A6-49D0-8E31-CCC4A391A953Q35509970-59C060CC-457A-472F-9C03-8D473C256129Q35714073-4A910F79-C523-4D86-9F99-8725222D7FACQ35737505-B9C83925-9DE3-48FA-9141-3D277FB8770DQ35796363-1CE26AF1-7CCE-4D33-8A16-9865FCFEBB0BQ35801416-21F556EE-3AFB-4655-A4C4-E5E1CCFD73AFQ35803174-102F89F1-8A0C-4BE2-9C91-B28D6CBAC9F6Q36001934-C1E1D5AB-86C1-4B52-90B1-4C8F8DF273B8Q36087104-FAB5F457-65CF-4A8A-8335-B738362F176EQ36193855-FF3A421D-AAD1-49E9-BE65-7033D9EA1965Q36453945-4AE423AB-4916-4158-9EC7-CFC0F5E33B32Q36618008-9818CB6C-D361-48A5-865A-6607C40EEFA9Q36968254-59F998F4-073B-4D2A-9E15-4D362A8635E3Q37523991-78EA07B2-BAC7-4306-97B9-8CF16C37C6E3Q37641479-1F58AA4C-69AB-4C3C-8E10-C9D22E825A73Q37871133-EAD0245C-1DE9-42F4-9DD0-9FFB1FFC5771Q38011003-A2CCB6E3-1CEE-4460-B483-60D264378C3BQ38084171-17BA301C-62CB-4972-A591-E611556A78C6Q38172176-06DAB7FE-9803-49E1-A9DA-83ADFB7D45FEQ38327802-F4357771-F58F-4A8A-B4CD-1C34DE978095Q39307792-E623F268-4FED-4BA8-B7A1-56845449FD15Q39504921-E60F9A75-0EBE-49F8-9C61-2F66C83C57F8Q40075691-610000FD-9D1C-4BD7-807E-09C6E7547C04Q41547771-C2150784-5116-4629-8545-B80AE10D6FAEQ41949585-F696F133-2631-4BF5-B95D-DFA636F1FF52Q43127865-E7F6A04D-0366-4A3C-989C-7282461CF4CDQ44726073-48868430-5F81-4877-84CB-FE1EA6A1EA03Q46145789-4784FAE3-5E9B-46F2-BDF3-A7C9A3D1FB51Q47109472-9C5AAF15-58C0-47E4-84D8-7DE6E53A17AEQ48326813-FEAF1480-E3B7-42B6-BECB-623E6EF763A7
P2860
A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
A comparison of the glutamate ...... n a model of neuropathic pain.
@en
A comparison of the glutamate ...... n a model of neuropathic pain.
@nl
type
label
A comparison of the glutamate ...... n a model of neuropathic pain.
@en
A comparison of the glutamate ...... n a model of neuropathic pain.
@nl
prefLabel
A comparison of the glutamate ...... n a model of neuropathic pain.
@en
A comparison of the glutamate ...... n a model of neuropathic pain.
@nl
P2093
P2860
P1476
A comparison of the glutamate ...... n a model of neuropathic pain.
@en
P2093
P2860
P304
P356
10.1111/J.1471-4159.2006.04304.X
P407
P577
2007-01-11T00:00:00Z